Nigeria allocates $150 million annually for vaccine procurement as global donor funding begins to shrink

The Federal Government spends $150M annually on vaccines. NPHCDA head Muyi Aina reports malaria vaccine expansion to Bauchi and Ondo despite shrinking aid.

By: AXL Media

Published: Apr 21, 2026, 9:58 AM EDT

Source: Information for this report was sourced from Daily Nigerian

Strategic Investment in Preventive Healthcare

The Nigerian government has revealed that its annual expenditure on vaccine procurement and related medical logistics has reached approximately $150 million. Dr. Muyi Aina, the Executive Director of the National Primary Health Care Development Agency, shared these figures during a 2026 quarterly briefing in Abuja. This substantial financial commitment covers not only the purchase of the vaccines themselves but also the complex infrastructure required for their delivery, including waste management systems, incinerators, and specialized cold chain equipment necessary to keep the doses viable.

Transitioning from International Donor Support

For years, Nigeria has relied heavily on a combination of federal allocations and support from international development partners, most notably Gavi, the Vaccine Alliance. However, Aina warned that global donor resources are shrinking, forcing a strategic shift toward domestic self sufficiency. As international aid declines, the federal government is being tasked with increasing its own financial contributions to ensure that routine immunization programs and outbreak responses are not compromised by a lack of external funding.

Expansion of Malaria Vaccination Rollout

Despite the tightening financial landscape, the government is moving forward with an expanded malaria vaccine initiative. Following successful pilot programs in Bayelsa and Kebbi, the rollout has now been extended to Bauchi and Ondo states. The malaria vaccine presents a unique logistical challenge, as it requires a strict four dose schedule to be effective. Health officials are currently grappling with high dropout rates between doses and are implementing new tracking systems to ensure children return for their full course of treatment.